Dr. Kim Han-gyeom of Hanaro Medical Foundation received a merit award from the Korean Society of Cytopathology for advancing cytopathology and providing medical education in underserved regions globally.
Medical Commercialization Blamed for Essential Care Decline
Lawyer Park Ho-gyun argues essential medical care decline stems from medical commercialization, not legal risks, opposing Medical Dispute Mediation Act amendments at emergency forum.
Daiichi Sankyo Korea launched Vanflyta (quizartinib), a targeted therapy for FLT3-ITD positive acute myeloid leukemia (AML), demonstrating survival benefits through full-cycle treatment strategy in global Phase 3 trials including elderly patients.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.
Get full access to view complete information
1 - 25 of 1.3K
Get full access to view complete information
Frequently Asked Questions Regarding 청년의사
Company Overview
1992
Founded
Healthcare
Industry
South Korea
Location
565,356,889
Ranking
0 employees
Size
Similar Companies
Get full access to view complete information
Frequently Asked Questions Regarding 청년의사
Start your journey today
Start with the platform — or start with a conversation
Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.